Form D · Biotechnology

CEBIX Inc

San Diego, CA · CIK 0001443443

Offering snapshot reported Nov 13, 2014 · SEC filing

Reported sold
$33.2M
Offering amount: $34.9M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 27, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$16.6M$33.2MSep 13, 2012: $12,938,338.00Sep 13, 2012Nov 13, 2014: $33,188,334.00Nov 13, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$12,938,338 → $33,188,334
  • Reported investors7 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 13, 2014Amendment$33,188,334$20,249,996vs Sep 13, 201210SEC filing
Sep 13, 2012Initial$12,938,338No comparison7SEC filing
Mar 9, 2012Amendment$8,799,305-$5,200,693vs Aug 31, 20105SEC filing
Aug 31, 2010Amendment$13,999,998$6,599,998vs Oct 30, 20097SEC filing
Oct 30, 2009Initial$7,400,000No comparison3SEC filing
Oct 23, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Aug 18, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Aug 18, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-184060

Source: Form D, filed Nov 13, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lars G. Ekman Director
James I. Healy Director
Callaway James Director, Executive
David Kabakoff Director
Nina Kjellson Director
Joel Martin Director, Executive
Michelle Morgan Executive
William Rohn Director
Pratik Shah Director
John Wahren Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
12520 High Bluff Drive, Suite 380
San Diego, CA, 92130